• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

B. Braun puts $20M in IV manufacturing expansion in Pennsylvania

September 19, 2025 By Sean Whooley

bbraun logo

B. Braun announced that it plans to invest $20 million to expand and modernize a medical device manufacturing facility in Pennsylvania.

The project should create at least 200 new, full-time jobs over the next three years and retain 1,704 existing positions at the Lehigh Valley plant. The Commonwealth of Pennsylvania put forth its support for the project with $1.5 million in state funding as well.

“Pennsylvania is a national leader in the biotech and life sciences industry thanks to our key location, research infrastructure, and skilled workforce,” said Pennsylvania Governor Josh Shapiro. “Having operated in the Lehigh Valley for more than 45 years, B. Braun recognizes the many advantages of doing their critical work here in Pennsylvania ― which is why they’re once again reinvesting in our Commonwealth. My administration and I are proud to support this expansion that will grow jobs, strengthen our life sciences sector, and help drive Pennsylvania’s economy forward.”

B. Braun plans to expand and modernize the equipment at the 710,000-square-foot medical device manufacturing facility in Hanover Township, near Allentown. It expects upgrades to enhance its IV therapy, pharmacy admixture and compounding operations products.

The company currently manufactures more than 2,400 medical devices and related products in Lehigh County. It plans to launch a new workforce training center at its Allentown site as well.

“We are proud to continue growing our manufacturing operations in the Lehigh Valley,” said Rob Albert, CEO, B. Braun of America. “Here in Pennsylvania, we have the skilled workforce, high quality suppliers, and business environment that enable us to manufacture medical devices used by healthcare providers across the United States. We appreciate the opportunity to partner with the Shapiro Administration to make our future even stronger.”

Filed Under: Business/Financial News, Drug-Device Combinations Tagged With: B. Braun

IN CASE YOU MISSED IT

  • MiniMed claims quick FDA clearance for Fit patch pump
  • Tandem’s Mobi pump wins FDA clearance for 7-day tubeless wearable set
  • Senseonics delivers ‘breakout quarter’ more than doubling Eversense 365 revenue
  • Tandem Diabetes Care names successor as CEO Sheridan retires
  • MiniMed names new CMO ahead of planned retirement

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS